Genix Pharmaceuticals Corporation
GENPF
$0.01
-$0.02-53.00%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.10K | 3.40K | 3.10K | 2.20K | 8.20K |
| Total Receivables | 1.20K | 700.00 | 2.00K | 4.90K | 4.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.00K | 11.30K | 20.60K | 27.50K | 15.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 36.40K | 15.30K | 25.70K | 34.50K | 27.80K |
|
|
|||||
| Total Current Assets | 36.40K | 15.30K | 25.70K | 34.50K | 27.80K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 4.30K | 4.50K | 4.50K | 4.90K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 36.40K | 19.60K | 30.20K | 39.00K | 32.70K |
|
|
|||||
| Total Accounts Payable | 115.70K | 125.00K | 121.10K | 118.90K | 107.30K |
| Total Accrued Expenses | 14.30K | 10.80K | 7.20K | 9.00K | 14.40K |
| Short-term Debt | 744.20K | 739.10K | 698.40K | 627.60K | 585.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 175.10K | 175.10K | 174.90K | 175.10K | 174.80K |
| Total Other Current Liabilities | 175.10K | 175.10K | 174.90K | 175.10K | 174.80K |
| Total Current Liabilities | 1.05M | 1.05M | 1.00M | 930.70K | 881.80K |
|
|
|||||
| Total Current Liabilities | 1.05M | 1.05M | 1.00M | 930.70K | 881.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 744.20K | 739.10K | 698.40K | 627.60K | 585.30K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.05M | 1.05M | 1.00M | 930.70K | 881.80K |
|
|
|||||
| Common Stock & APIC | 6.96M | 7.01M | 7.02M | 6.70M | 6.96M |
| Retained Earnings | -8.95M | -8.99M | -8.95M | -8.51M | -8.76M |
| Treasury Stock & Other | 970.40K | 953.70K | 955.20K | 912.00K | 947.20K |
| Total Common Equity | -1.01M | -1.03M | -971.50K | -891.60K | -849.10K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.01M | -1.03M | -971.50K | -891.60K | -849.10K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.01M | -1.03M | -971.50K | -891.60K | -849.10K |
|
|
|||||